Open mitochondrial research · Plain-language explainer

Published on Zenodo · September 11, 2026

Sequence to function profiling of POLG TWNK and MTHFR variants

Friedl, Andrew

Abstract

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

DOI: 10.5281/zenodo.22712218

Read the full paperRead the public summary

The paper at a glance

The question

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

Main takeaway

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

Important caution

This is a research synthesis, not clinical guidance. The paper describes uncertainty and limits in the underlying evidence.

Why this matters

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

How the research was done

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

What the researchers found

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

What this does not prove

This is a research synthesis, not clinical guidance. The paper describes uncertainty and limits in the underlying evidence.

What researchers should test next

AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production.

For non-specialists

What this could mean for patients and families

This research helps organize how scientists think about sequence to function profiling of polg twnk and mthfr variants. AlphaGenome was applied to five participant-provided variants in POLG, TWNK, and MTHFR. The exploratory profiles distinguish protein-centered predictions from secondary regulatory hypotheses but do not establish pathogenicity, clinical severity, or causal effects on energy production. It does not establish a diagnosis, prove that a treatment works, or tell an individual person what care to pursue.

  • What was directly measured, and what was inferred?
  • Were the findings in people, animals, cells, or a mixture?
  • What result would disprove or narrow the proposed explanation?
Track symptoms and function over time →Join Mito Map as a researcher →